Get started
Author

Katia Pauwels

State-of-the-Art Lentiviral Vectors for Research Use: Risk Assessment and Biosafety Recommendations
2009 · Katia Pauwels, Rik Gijsbers, et al. · Current Gene Therapy · 124
Biosafety aspects of modified vaccinia virus Ankara (MVA)-based vectors used for gene therapy or vaccination
2012 · Céline Verheust, Martine Goossens, et al. · Vaccine · 103
Engineering nucleases for gene targeting: safety and regulatory considerations
2013 · Katia Pauwels, Nancy Podevin, et al. · New Biotechnology · 93
General Considerations on the Biosafety of Virus-derived Vectors Used in Gene Therapy and Vaccination
2014 · Aline Baldo, Eric den Akker, et al. · Current Gene Therapy · 74
PDF
A New Yeast Metabolon Involving at Least the Two First Enzymes of Arginine Biosynthesis
2001 · Agnes Abadjieva, Katia Pauwels, et al. · Journal of Biological Chemistry · 72
PDF
Next-generation sequencing as a tool for the molecular characterisation and risk assessment of genetically modified plants: Added value or not?
2015 · Katia Pauwels, Sigrid C.J. De Keersmaecker, et al. · Trends in Food Science & Technology · 59
Contained use of Bacteriophages: Risk Assessment and Biosafety Recommendations
2010 · Céline Verheust, Katia Pauwels, et al. · Applied Biosafety · 59
PDF
Commentary: Genetic modification through oligonucleotide-mediated mutagenesis. A GMO regulatory challenge?
2009 · Didier Breyer, Philippe Herman, et al. · Environmental Biosafety Research · 49
PDF
TheN‐acetylglutamate synthase/N‐acetylglutamate kinase metabolon ofSaccharomyces cerevisiaeallows co‐ordinated feedback regulation of the first two steps in arginine biosynthesis
2003 · Katia Pauwels, Agnes Abadjieva, et al. · European Journal of Biochemistry · 47
PDF
Animal Cell Cultures: Risk Assessment and Biosafety Recommendations
2007 · Katia Pauwels, Philippe Herman, et al. · Applied Biosafety · 21
The Yeast ARG7 Gene Product Is Autoproteolyzed to Two Subunit Peptides, Yielding Active Ornithine Acetyltransferase
2000 · Agnes Abadjieva, Pierre Hilven, et al. · Journal of Biological Chemistry · 21
Environmental Risk Assessment of Clinical Trials Involving Modified Vaccinia Virus Ankara (MVA)-Based Vectors
2014 · Martine Goossens, Katia Pauwels, et al. · Current Gene Therapy · 20
PDF
Environmental Risk Assessment of Recombinant Viral Vector Vaccines against SARS-Cov-2
2021 · Aline Baldo, Amaya Leunda, et al. · Vaccines · 19
PDF
Oncolytic Viruses: An Inventory of Shedding Data from Clinical Trials and Elements for the Environmental Risk Assessment
2023 · Sheela Onnockx, Aline Baldo, et al. · Vaccines · 18
PDF
Biosafety Recommendations on the Handling of Animal Cell Cultures
2014 · Philippe Herman, Katia Pauwels · Cell engineering · 15
PDF
Biosafety of Molecular Farming in Genetically Modified Plants
2011 · Didier Breyer, Adinda De Schrijver, et al. · Springer eBooks · 14
Event report: SynBio Workshop (Paris 2012) – Risk assessment challenges of Synthetic Biology
2013 · Katia Pauwels, Ruth Mampuys, et al. · Journal of Consumer Protection and Food Safety · 13
Biosafety Recommendations for the Contained Use of Mycobacterium tuberculosis Complex Isolates in Industrialized Countries.
2006 · Philippe Herman, Maryse Fauville‐Dufaux, et al. · 13
Are ‘OMICS’ Contributing to the Identification of Unintended Effects in Genetically Modified Crops?
2012 · Katia Pauwels · Biosafety · 4
GMO Regulatory Aspects of Novel Investigational Vaccine Candidates
2019 · Amaya Leunda, Katia Pauwels · IntechOpen eBooks · 3
PDF
Biosafety Risk Assessment and Management of Laboratory-Derived Influenza A (H5N1) Viruses Transmissible in Ferrets
2013 · Aline Baldo, Amaya Leunda, et al. · Applied Biosafety · 3
Contributions from scientific research to the risk assessment of GMOs. Lessons learned from a symposium held in Brussels, Belgium, 21–22 October 2010
2010 · Katia Pauwels, Didier Breyer, et al. · Environmental Biosafety Research · 3
PDF
Should Novel Organisms Developed Using Oligonucleotide-mediated Mutagenesis be Excluded from the EU Regulation on GMOs?
2009 · Didier Breyer, Philippe Herman, et al.
Works count: 30
Citation count: 847
H-index: 15
I10-index: 18
Year
Topic
Type